Design and optimization of selective serotonin re-uptake inhibitors with high synthetic accessibility Part 1.

摘要

The reported selective serotonin Re-uptake Inhibitor Litoxetine was used as the starting point in the design of a range of potential SSRIs with high ease of synthetic accessibility. Preparation and subsequent optimization yielded a range of potent and highly selective SSRIs.